ENDOMETRIAL NEOPLASMS
Clinical trials for ENDOMETRIAL NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new ENDOMETRIAL NEOPLASMS trials appear
Sign up with your email to follow new studies for ENDOMETRIAL NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise against tough uterine cancer
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and lenvatinib, against standard chemotherapy for women with advanced or recurrent endometrial cancer. The goal was to see if the combo could help people live longer without their cancer growing. The study involved 842 p…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
Promising combo slows advanced uterine cancer in large trial
Disease control CompletedThis phase 3 trial tested whether combining two drugs, lenvatinib and pembrolizumab, works better than standard chemotherapy for people with advanced endometrial cancer that has returned or spread. Over 800 participants were randomly assigned to receive either the drug combo or a…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE3 • Sponsor: Eisai Inc. • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New drug combo shows promise against tough uterine cancer
Disease control CompletedThis study tested whether a combination of two drugs (pembrolizumab and lenvatinib) works better than standard chemotherapy for women with advanced or recurrent endometrial cancer. About 130 women with stage III, IV, or recurrent disease took part. The goal was to see if the comb…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New EHR tool sparks heart-health talks for cancer survivors
Knowledge-focused CompletedThis study tested a computer tool that helps doctors and cancer survivors discuss heart health during follow-up visits. 645 survivors of breast, prostate, colorectal, endometrial, or lymphoma cancers took part. The tool aimed to increase conversations about heart risks and referr…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
New dye technique may help surgeons spot hidden cancer cells in real time
Knowledge-focused CompletedThis study tested a new method for injecting a green dye to help surgeons find lymph nodes during robotic surgery for early-stage endometrial cancer. The new method uses real-time imaging to guide the injection, aiming to find more lymph nodes on both sides of the pelvis. 80 pati…
Matched conditions: ENDOMETRIAL NEOPLASMS
Phase: NA • Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC